Forster awarded Denham Harman Award for aging research

Michael Forster UNTHSCFor more than three decades, Michael Forster, PhD, has studied ways to slow the aging process and help people live longer, healthier lives.

In May, the American Aging Association will present Dr. Forster, Chair of Pharmacology & Neuroscience, with the Denham Harman Research Award. Named after the association’s co-founder, the award honors those who have made significant contributions to biomedical aging research.

In keeping with the association’s mission, Dr. Forster said one of his goals has been to promote aging research and help the public recognize the difference between “science and snake oil.”

“As a function of chronological aging, biological changes occur, and those vulnerabilities set the stage for diseases such as Alzheimer’s and diabetes,” he said. “By understanding the primary forces of aging and slowing them down, we may be able to prevent or treat these diseases.”

Much of Dr. Forster’s research has focused on the role of oxidative stress in age-associated brain dysfunction and in the anti-aging effects of caloric restriction. Along with UNTHSC colleagues, Dr. Forster also has studied the role exercise plays in delaying aging.

“Exercise and calorie restriction appear to be ways that the aging process can be regulated,” he said. “We’re also studying whether the longer a person’s weight is maintained at a high level, the greater the amount of aging as measured by life-span.”

Dr. Forster said he always has considered the Denham Award an unreachable honor.

This lifetime achievement in aging research award is a huge honor, said Meharvan Singh, PhD, Dean of the Graduate School of Biomedical Sciences.

“It pays tribute to Dr. Forster’s career-long commitment to the study of brain aging and the significant discoveries he has made along the way,” Dr. Singh said. “I can’t help but feel an immense sense of pride to have Dr. Forster as a colleague and a member of the UNTHSC faculty.”

Recent News

One pill kills graphic
  • On Campus
|Oct 2, 2023

HSC launches One Pill Kills Campaign to combat fentanyl

A synthetic opioid that’s considered exponentially more addictive than heroin, fentanyl is now the leading cause of death for Americans ages 18 to 49. It can be fatal to ingest even a tiny amount, so small it could fit on a pencil eraser. In the face of the deadliest epidemic in the history o...
  • Our People
|Sep 29, 2023

Dr. Michael Clearfield the inaugural winner of the Beyer, Everett, and Luibel Memorial Medal

For more than two decades, Dr. Michael B. Clearfield, DO, MACOI, FACP, has developed the Department of Internal Medicine and Geriatrics at the Texas College of Osteopathic Medicine into one of the largest and most productive academically in the osteopathic profession, serving as the chair from 1982-...
Kari Northeim 2 (002)[66]
  • Our People
|Sep 28, 2023

HSC’s Dr. Kari Northeim and Parker County collaborators awarded SAMHSA grant for rural EMS training and education

Dr. Kari Northeim, School of Public Health assistant professor of population and community health at The University of North Texas Health Science Center at Fort Worth, has been awarded the SAMHSA Rural EMS Training and Education grant in conjunction with HSC community partners, Parker County Hospi...
Graci Finco
  • Research
|Sep 28, 2023

SBS researchers publish innovative study in Nature Scientific Reports 

People with leg amputations, including those with diabetes, run the risk of overuse injuries like osteoarthritis, muscle atrophy or bone breaks in their intact limbs.   Now, new research is quantifying the impacts of amputations and diabetes, a leading cause of amputation, on those overuse ...